| Authors: |
Xu Y; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Carrascosa LC; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Yeung YA; BMD, Pfizer Inc., San Diego, California., Chu ML; BMD, Pfizer Inc., San Diego, California., Yang W; Computational Biology, Pfizer Inc., San Diego, California., Djuretic I; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Pappas DC; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Zeytounian J; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Ge Z; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., de Ruiter V; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Starbeck-Miller GR; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Patterson J; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Rigas D; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Chen SH; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kraynov E; BMD, Pfizer Inc., San Diego, California., Boor PP; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Noordam L; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Doukas M; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands., Tsao D; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Ijzermans JN; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Guo J; BMD, Pfizer Inc., San Diego, California., Grünhagen DJ; Surgery, Erasmus Medical Center, Rotterdam, the Netherlands., Erdmann J; Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Verheij J; Pathology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Royen ME; Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.; Cancer Treatment Screening Facility (CTSF), Erasmus Medical Center, Rotterdam, the Netherlands., Doornebosch PG; Surgery, IJsselland Hospital, Capelle aan den IJssel, the Netherlands., Feldman R; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Park T; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Mahmoudi S; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Dorywalska M; BMD, Pfizer Inc., San Diego, California., Ni I; BMD, Pfizer Inc., San Diego, California., Chin SM; BMD, Pfizer Inc., San Diego, California., Mistry T; BMD, Pfizer Inc., San Diego, California., Mosyak L; BMD, Pfizer Inc., San Diego, California., Lin L; BMD, Pfizer Inc., San Diego, California., Ching KA; Computational Biology, Pfizer Inc., San Diego, California., Lindquist KC; BMD, Pfizer Inc., San Diego, California., Ji C; DSRD, Pfizer Inc., San Diego, California., Londono LM; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kuang B; BMD, Pfizer Inc., San Diego, California., Rickert R; Cancer Immunology Discovery, Pfizer Inc., San Diego, California., Kwekkeboom J; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands., Sprengers D; Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com., Huang TH; Cancer Immunology Discovery, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com., Chaparro-Riggers J; BMD, Pfizer Inc., San Diego, California. javier.chaparro-riggers@pfizer.com d.sprengers@erasmusmc.nl tzu-hsuan.huang@pfizer.com. |
